226 related articles for article (PubMed ID: 26527781)
1. Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
Ji Y; Rankin C; Grunberg S; Sherrod AE; Ahmadi J; Townsend JJ; Feun LG; Fredericks RK; Russell CA; Kabbinavar FF; Stelzer KJ; Schott A; Verschraegen C
J Clin Oncol; 2015 Dec; 33(34):4093-8. PubMed ID: 26527781
[TBL] [Abstract][Full Text] [Related]
2. Role of antiprogestational therapy for meningiomas.
Grunberg SM
Hum Reprod; 1994 Jun; 9 Suppl 1():202-7. PubMed ID: 7962466
[TBL] [Abstract][Full Text] [Related]
3. Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.
Grunberg SM; Weiss MH; Russell CA; Spitz IM; Ahmadi J; Sadun A; Sitruk-Ware R
Cancer Invest; 2006 Dec; 24(8):727-33. PubMed ID: 17162554
[TBL] [Abstract][Full Text] [Related]
4. [Multiple usages for antiprogestins].
Heikinheimo O
Duodecim; 1994; 110(10):1001-8. PubMed ID: 7588093
[No Abstract] [Full Text] [Related]
5. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.
Grunberg SM; Weiss MH; Spitz IM; Ahmadi J; Sadun A; Russell CA; Lucci L; Stevenson LL
J Neurosurg; 1991 Jun; 74(6):861-6. PubMed ID: 2033444
[TBL] [Abstract][Full Text] [Related]
6. Mifepristone (RU 486) treatment of meningiomas.
Lamberts SW; Tanghe HL; Avezaat CJ; Braakman R; Wijngaarde R; Koper JW; de Jong H
J Neurol Neurosurg Psychiatry; 1992 Jun; 55(6):486-90. PubMed ID: 1619417
[TBL] [Abstract][Full Text] [Related]
7. The role of mifepristone in the management of meningiomas: A systematic review of literature.
Sharma R; Garg K; Katiyar V; Tandon V; Agarwal D; Singh M; Chandra SP; Suri A; Kale SS; Mahapatra AK
Neurol India; 2019; 67(3):698-705. PubMed ID: 31347538
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486).
Touat M; Lombardi G; Farina P; Kalamarides M; Sanson M
Acta Neurochir (Wien); 2014 Oct; 156(10):1831-5. PubMed ID: 25078073
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for meningiomas.
Kyritsis AP
J Neurooncol; 1996 Sep; 29(3):269-72. PubMed ID: 8858533
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
[TBL] [Abstract][Full Text] [Related]
11. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Altinoz MA; Ozpinar A; Elmaci I
Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
[TBL] [Abstract][Full Text] [Related]
12. Large endometrial polyp in a patient on long-term mifepristone therapy.
Martineau PA; Levental M
J Ultrasound Med; 2000 Jul; 19(7):487-9. PubMed ID: 10898303
[No Abstract] [Full Text] [Related]
13. Clinical applications of the antiprogestins.
Kettel LM
Clin Obstet Gynecol; 1995 Dec; 38(4):921-34. PubMed ID: 8616987
[No Abstract] [Full Text] [Related]
14. Mifepristone: antineoplastic studies.
Sartor O; Figg WD
Clin Obstet Gynecol; 1996 Jun; 39(2):498-505. PubMed ID: 8734014
[TBL] [Abstract][Full Text] [Related]
15. Management of patients receiving long-term treatment with mifepristone.
Spitz IM; Grunberg SM; Chabbert-Buffet N; Lindenberg T; Gelber H; Sitruk-Ware R
Fertil Steril; 2005 Dec; 84(6):1719-26. PubMed ID: 16359971
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Mazza E; Brandes A; Zanon S; Eoli M; Lombardi G; Faedi M; Franceschi E; Reni M
Cancer Chemother Pharmacol; 2016 Jan; 77(1):115-20. PubMed ID: 26659583
[TBL] [Abstract][Full Text] [Related]
17. [Hydroxyurea treatment for unresectable meningioma].
Fuentes S; Chinot O; Dufour H; Paz-Paredes A; Métellus P; Barrie-Attarian M; Grisoli F
Neurochirurgie; 2004 Sep; 50(4):461-7. PubMed ID: 15547484
[TBL] [Abstract][Full Text] [Related]
18. Treatment for rare brain tumors veers from traditional tack.
McBride G
J Natl Cancer Inst; 1997 Jul; 89(13):912-3. PubMed ID: 9214668
[No Abstract] [Full Text] [Related]
19. Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy.
Simó M; Argyriou AA; Macià M; Plans G; Majós C; Vidal N; Gil M; Bruna J
Cancer Chemother Pharmacol; 2014 May; 73(5):919-23. PubMed ID: 24619496
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]